Recently added articles from Biopharm International:
A True Assessment of Risk
Sep 01, 2009; ... Risk assessment exercises seem pretty simple. Make a list of everything that could go wrong. Quantify those risks, by assigning scores. Then decide if you need to do more to prevent the high-risk events from happening. Tedious, but not complicated. The recent CMC Strategy Forum on ...
Vaccine Report
Sep 01, 2009; ... New Vaccine Produced in Tobacco Plants A new vaccine for norovirus has been produced i? tobacco plants, a scientist reported on August 18 at the national meeting of the American Chemical Society (ACS) in Washington DC. The new vaccine was "manufactured" in a tobacco plant using ...
Six Steps to Improve FDA Enforcement
Sep 01, 2009; ... FDA Acting Commissioner Margaret Hamburg outlined six steps to improve FDA enforcement in a speech given on August 6, eight weeks into her tenure. Hamburg said that the current pathways for enforcement can be too long and arduous when the public's health at risk. To improve the pathway, ...
SAFC Develops First Chemically Defined Hydrolysate Replacement
Sep 01, 2009; ... SAFC Biosciences (St. Louis, MO) has developed a chemically defined cell culture supplement as a replacement for undefined plant hydrolysates. The product, Ex-Cell CD Hydrolysate Fusion, is designed for biopharmaceutical cell culture processes using Chinese hamster ovary, NSO, and Sp2/0 cell ...
Biopharmaceutical Manufacturers Seize Opportunities in the Global Health Arena
Sep 01, 2009; ... The FDA is encouraging manufacturers to invest in R&D for new vaccines and therapeutics to combat third-world diseases The need to strengthen public health at home and abroad is expanding the development of new medicines and vaccines to prevent and treat infectious diseases around ...